T2Mc company information, Employees & Contact Information

De Kuyper and Lucas Bols to sell Avandis The Spirits Business

Lucas Bols and De Kuyper to sell Avandis to Refresco for €25m FoodBev Media

Netherlands Lucas Bols, De Kuyper sell spirits manufacturer Avandis Just Drinks

Refresco Completes Acquisition Of Alcoholic Beverage Firm Avandis ESM Magazine

De Kuyper, Lucas Bols to sell Avandis spirits production JV to Refresco Global Drinks Intel

Avandia Lawsuits Drugwatch.com

Bittersweet victory for GSK's Avandia Chemistry World

Think Women’s 40 Outstanding Global Women 2023 - Dr Anino Emuwa, Avandis Consulting Relocate magazine

Avandia, a Type 2 Diabetes Drug, Poses Heart Risks, Study Confirms Everyday Health

Avandia: Side effects, dosage, alternatives, and more Medical News Today

Revisiting the Avandia Scare: Results from the RECORD Trial Making Sense of Diabetes

FDA Criticized for Diabetes Drug Avandia NPR

F.D.A. Lifts Some Restrictions on Avandia (Published 2013) The New York Times

After the Headlines, What Is the Real Avandia Story? ABC News - Breaking News, Latest News and Videos

Information Page: FDA requires removal of certain restrictions on the diabetes drug Avandia fda.gov

Reviewer leaked Avandia study to drug firm Nature

Avandia and diabetes: Was revolution worth the risks? CNN

F.D.A. to Reconsider Restrictions on Diabetes Drug (Published 2013) The New York Times

F.D.A. to Restrict Avandia, Citing Heart Risk (Published 2010) The New York Times

Glaxo Settles Cases With U.S. for $3 Billion (Published 2011) The New York Times

Report: GSK Knew Avandia's Risks for Years CBS News

Q&A: Avandia BBC

Dismantling Avandia, Actos and the TZDs Making Sense of Diabetes

Settlement of Avandia Lawsuits Reached in About 10,000 More Cases AboutLawsuits.com

Avandia Lawsuit Settlement of $60M Will Resolve 700 Cases: Report AboutLawsuits.com

Lucas Bols, De Kuyper and Refresco announce the completion of the sale of Avandis about-drinks.com

Research Ties Diabetes Drug to Heart Woes (Published 2010) The New York Times

Key diabetes drug study was flawed, review charges CNN

Avandia withdrawal from shelves by November: FDA News-Medical

Did FDA Know Of Avandia Dangers In 2002? CBS News

Avandia Settlements Reportedly Reached in Thousands More Lawsuits AboutLawsuits.com

European Agency Reviewing Cardiovascular Safety Of GlaxoSmithKline's Avandia RTTNews

What did the FDA Know About Avandia? CBS News

FDA reverses course on Avandia warning, lifts safety restrictions CBS News

Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings Forbes

Families face battle with GSK over dangerous diabetes drug The Guardian

Rémy Cointreau exits Passoã joint venture The Spirits Business

Glaxo Agrees to Pay $3 Billion in Fraud Settlement (Published 2012) The New York Times

“I help women rise and organisations to build diverse leadership teams": Dr. Anino Emuwa, Managing Director, Avandis Consulting, Founder, 100 Women@Davos Institute of Directors

Diabetes drug Avandia pulled in Europe CBC

Rosiglitazone (Avandia) and macular edema CMAJ

GlaxoSmithKline pleads guilty in $3B US drug fraud case CBC

Diabetes drug Avandia gets heart warnings CBC

Avandia banned in the UK diabetes.co.uk

Canada weighs tighter rules on Avandia diabetes drug The Globe and Mail

Avandi the ideal man for Estonian women, Russians prefer Savisaar and Putin ERR

Avandia survives Jamaica Gleaner

Ministry suspends sale of Avandia in UAE Emirates24|7

Dangerous diabetes drug Avandia on sale in Kenya The EastAfrican